JP: I wonder how soon they could publicly announce "work orders" from pharms doing trials? Even though the trial might not start for a couple of months and the revenue not paid until then, a "work order" would be music to shareholder's ears.

I think this is a psychological thing. Once the Lympro revenue machine gets revved up (as in "work orders" shareholders know there will be plenty more "work orders" coming after that. That would be a huge positive sign. This stock would shoot up fast.